15 octubre 2014
Nanomedicines consisting of nanoparticles for targeted drug delivery to specific tissues and cells offer new solutions for cancer diagnosis and therapy. In a recent study, researchers systematically evaluated the size-dependent biological profiles of three monodisperse drug-silica nanoconjugates to determine the optimum particle size for tissue penetration and tumor inhibition.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/8PjA35c9vb0/141015165605.htm
